ERBB2 and neoplasm: COX-2 expression is correlated with prognostic markers that reflect a poor chance for survival, which includes tumour size, axillary node metastases, tumour grade, ductal histology, receptor negative disease and HER-2 amplification (Ristimaki et al, 2002; Boland et al, 2004).